Constrictive Tuberculous Pericarditis When Standard Antituberculosis Therapy Has Not Resolved the Constriction

Tuberculous pericarditis can present as constrictive pericarditis, in which fibrosis of the pericardium restricts cardiac filling. For patients in whom an initial course of medical therapy has not achieved resolution of the constriction, a defined escalation step applies.

Tuberculous pericarditis presents clinically in several forms, including constrictive pericarditis. This protocol addresses the specific situation of pericardial tuberculosis presenting as constrictive pericarditis.

Prior Therapy and Why It Was Not Sufficient

The first-line approach consists of standard antituberculosis drugs for 6 months, with a trial of medical therapy recommended for noncalcific pericardial constriction. This protocol is indicated when that course has failed to achieve its primary goal: resolution of constriction within 6 months of antituberculosis chemotherapy.

Next Step in Management

For persistent constriction that has not responded to antituberculosis chemotherapy, management involves a surgical intervention directed at the pericardium. The full protocol — including specific indications, timing criteria, and the complete decision pathway — is available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

Tuberculous pericarditis presents clinically in 3 forms, namely, pericardial effusion, constrictive pericarditis, and a combination of effusion and constriction.

The treatment of tuberculous pericardial constriction involves the use of standard antituberculosis drugs for 6 months and pericardiectomy for persistent constriction in the face of drug therapy.

The timing of surgical intervention is controversial, but many experts recommend a trial of medical therapy for noncalcific pericardial constriction, and pericardiectomy in nonresponders after 4 to 8 weeks of antituberculosis chemotherapy.

DOI: 10.1161/circulationaha.105.543066

View source ↗